|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/475 | |
| C07K 14/65 | |||
| C07K 16/12 | |||
| C07K 16/40 | |||
| C12N 9/90 | |||
| G01N 33/573 | |||
| G01N 33/74 | |||
| C07K 16/22 |
| (11) | Number of the document | 2705053 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12717787.1 |
| Date of filing the European patent application | 2012-05-04 | |
| (97) | Date of publication of the European application | 2014-03-12 |
| (45) | Date of publication and mention of the grant of the patent | 2017-06-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/058208 |
| Date | 2012-05-04 |
| (87) | Number | WO 2012/150321 |
| Date | 2012-11-08 |
| (30) | Number | Date | Country code |
| 11164957 | 2011-05-05 | EP | |
| 12155742 | 2012-02-16 | EP |
| (72) |
ANDRES, Herbert, DE
DUEFEL, Hartmut, DE
GERG, Michael, DE
KOWALEWSKY, Frank, DE
SCHOLZ, Christian, DE
SCHRAEML, Michael, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
Roche Diagnostics GmbH, Sandhofer Stra e 116, 68305 Mannheim, DE |
| (54) | AN ANTIBODY SPECIFICALLY BINDING TO INSULIN-LIKE GROWTH FACTOR-1 |
| AN ANTIBODY SPECIFICALLY BINDING TO INSULIN-LIKE GROWTH FACTOR-1 |